Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Sodium-Glucose Cotransporter 2 Inhibitor [EPC] — Common Side Effects

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Side Effect Total Reports Drugs Deaths Hosp. Life-Threat.
Diabetic ketoacidosis 7,604 3 157 5,831 1,127
Fungal infection 4,546 4 14 222 46
Death 4,392 4 4,385 133 27
Weight decreased 3,461 4 49 550 102
Blood glucose increased 3,360 4 17 571 118
Acute kidney injury 3,118 3 152 2,496 423
Urinary tract infection 2,963 4 67 1,197 149
Dizziness 2,626 4 26 435 59
Nausea 2,387 4 34 896 222
Toe amputation 2,369 3 20 1,736 16
Osteomyelitis 2,222 3 21 1,861 15
Ketoacidosis 2,147 3 73 1,299 503
Euglycaemic diabetic ketoacidosis 2,137 3 65 1,623 431
Dehydration 1,952 4 50 1,051 195
Vomiting 1,843 4 64 1,056 270
Drug ineffective 1,822 4 17 227 29
Pollakiuria 1,803 4 11 170 35
Diarrhoea 1,778 4 29 480 99
Off label use 1,700 4 41 578 85
Fatigue 1,510 4 23 288 72
Fournier's gangrene 1,462 3 87 1,061 337
Glycosylated haemoglobin increased 1,439 3 6 178 22
Dyspnoea 1,422 4 64 543 168
Malaise 1,289 4 32 433 113
Rash 1,216 4 6 154 24
Gangrene 1,216 3 15 1,027 18
Asthenia 1,207 4 61 461 121
Cellulitis 1,193 3 13 1,027 14
Myocardial infarction 1,179 4 123 494 95
Sepsis 1,177 3 78 1,029 183
← Back to Sodium-Glucose Cotransporter 2 Inhibitor [EPC] Compare drugs in this class →